14Indexed trials
mesh condition
Neuromyelitis Optica
Intelligence
Neuromyelitis Optica intelligence: 14 indexed trials, 7 recruiting studies, 11 sponsors across 16 countries.
7Recruiting
11Sponsors
16Countries
Leading sponsors
Tianjin Medical University General Hospital32 recruiting
Amgen22 recruiting
Fu-Dong Shi10 recruiting
Johns Hopkins University10 recruiting
Michael, Levy M.D.,Ph.D.10 recruiting
Tang-Du Hospital11 recruiting
Tongji Hospital11 recruiting
University Hospital Center of Martinique10 recruiting
University of Calgary10 recruiting
Xuanwu Hospital, Beijing10 recruiting
Assistance Publique Hopitaux De Marseille11 recruiting
Geographic activity
China8trials
United States4trials
France3trials
Poland2trials
Canada2trials
Czechia1trials
Hungary1trials
Netherlands1trials
Argentina1trials
Serbia1trials
South Korea1trials
Spain1trials
Leading interventions
Inebilizumab2trials
AHSCT1trials
Azathioprine1trials
BAFF-R CART1trials
Baricitinib1trials
Blood tests1trials
Calculus bovis sativus (CBS)1trials
Imaging Techniques (MRI 3T & 7T, Functional, Structural, and Metabolic Imaging)1trials
Mitoxantrone1trials
Nabiximols1trials
Neuro-ophtalmology examination1trials
Scrambler1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.